Episode 176: Antiracism in Medicine Series – ...

Kaylin, Sharmin, and Cheryl are joined by Kassidy Lovins, MS3, and Ann Marie Kumfer, MD, to discuss a case of a 35-year-old man with fevers, diffuse myalgias, and weakness. Bio:Kassidy Lovins is a third-year student at UNC School of Medicine, approaching the end of her clinical r ...  Show more

RLR ready Episode description RR discussed a case presented by Shantanu Rai involving a young woman with four months of fever. The case is adapted from a novel written by Shantanu Rai. – author/book website: www.shantanurai.com – author email: shantanuraiauthor@gmail.com – where ...  Show more

Certain medical instruments have built-in methods of correcting for race. They're based on the premise that Black bodies are inherently different from White bodies. The tool that measures kidney function, for example, underestimates how severe some Black patients' kidney disea ...

In 2005 the FDA approved a pill to treat high blood preassure only in African Americans. This so-called miracle drug was named BiDil, and it became the first race-specific drug in the United States. It might sound like a good a good thing, but it had the unintended consequence ...

Addressing racial diversity amongst doctors can improve outcomes for people in their local communities. We speak to Dr Monica Peek, Doctor of Internal Medicine and Professor for Health Justice of Medicine at the University of Chicago, about a new study showing that a 10 per cent ...  Show more

In the past two decades, media images of the surprisingly white “new face” of the US opioid crisis abounded. But why was the crisis so white? Some argued that skyrocketing overdoses were “deaths of despair” signaling deeper socioeconomic anguish in white communities. Whiteout: Ho ...  Show more